SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-004117
Filing Date
2024-07-09
Accepted
2024-07-09 06:01:24
Documents
95
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q upxi_10q.htm   iXBRL 10-Q 1490298
2 CERTIFICATION upxi_ex311.htm EX-31.1 8160
3 CERTIFICATION upxi_ex312.htm EX-31.2 8193
4 CERTIFICATION upxi_ex321.htm EX-32.1 3417
5 CERTIFICATION upxi_ex322.htm EX-32.2 3460
  Complete submission text file 0001477932-24-004117.txt   7659614

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA upxi-20240331.xsd EX-101.SCH 85473
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20240331_lab.xml EX-101.LAB 445760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20240331_cal.xml EX-101.CAL 80112
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20240331_pre.xml EX-101.PRE 398396
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20240331_def.xml EX-101.DEF 248975
98 EXTRACTED XBRL INSTANCE DOCUMENT upxi_10q_htm.xml XML 1302753
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

IRS No.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40535 | Film No.: 241106247
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)